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Introduction
It is highly probable that all of us have had at least one experience of being a patient or caregiver. Whether you or a loved one suffer from a chronic illness, had an acute medical event, got a prescription filled, assist a parent or grandparent, or experienced well-child visits, you certainly expected to receive quality services. Reflecting on those encounters, did you actually receive services at the quality you expected? How would you make that determination? What does a quality medical encounter look and feel like? Is it the wait time, friendliness and empathy of the providers, or improvement in how you feel? Or is it that you have a better understanding of your medical condition and how to manage it? How do you know if you received the right information, the right test, and the right therapy?
As a health care professional, your understanding of our complex health system may allow you to definitively evaluate your experience. Consider, however, those without the inner knowledge of the health system such the patients and caregivers you encounter daily in your practice. How would most of them answer the above questions? In my practice, I witness failures in quality almost on a daily basis, and I suspect that is the case for most pharmacists. Gaps in quality are common, and quality failures are so frequent and overwhelming that we find ourselves impervious to the minor ones and responding only to the most egregious occurrences.
I hope this exercise of reflecting on the quality of your own personal experiences has you contemplating and raising some very important questions. What exactly does quality mean?
There are numerous perspectives to consider in the gamut from patients to payers. Whose version of quality should we focus on? If we consider only the patient's perspective, is that sufficient? The amount of information, unanswered questions, and demands in the quality arena are quickly escalating. The enormity of the task at initial glance is quite overwhelming, and pressures continue to mount from the government, payers, and work sites for proof that all 3 providers are delivering quality services. The stakes may be even higher for ambulatory care pharmacists who are forging new roles in practice models that are not yet fully tested.
There is much evidence for the need to improve quality in the U.S. health care system.
The rhetoric on quality is intensifying, and the path to achieving quality and, in particular, quality around medication use, is not very clear. Continuously improving the quality of service to our patients needs to be a high priority. The aim of this paper is to improve the understanding of this enormous topic among ambulatory care pharmacists so they can effectively address it in their daily practice.
Defining quality
There is no consensus on the definition of quality in health care. [1] [2] [3] [4] To elderly confused patients, quality may mean that the provider was kind to them; to busy executives, quality may mean a short waiting time or minimal time for an appointment carved out of their busy day; to physicians, quality may mean correct diagnoses; and to pharmacists, quality may mean that the recommended therapy achieved the desired outcome. A health administrator may look at efficiency of clinical services, and the payer may view generic medication use as a marker of quality.
The Institute of Medicine (IOM) defines quality as the degree to which health services for individuals or populations increase the likelihood of desired health outcomes that are consistent with current professional knowledge. 5 The beauty of this definition is that it connects quality to the experiences of individual patients and their outcomes, where it must start, and broadens the scope to populations, which is the measuring stick for most judgments about quality. This understanding of individual patient needs that seamlessly broaden into population needs is important in building successful quality improvement programs.
The basics of quality measurement and improvement
Ambulatory care pharmacists must stay abreast of many quality improvement initiatives.
All are important in order to prove value and sustain growth of ambulatory care services. The first step is to gain a basic understanding of the language, theory, and current standard processes for quality improvement.
Quality primer. Twenty-five years ago, Donabedian proposed a construct to determine and measure quality in health care around three domains that remain in use today 6 :
• Structure-how resources and systems effect patient care,
• Process-how the provider-patient interactions and the care and services provided affect the patient, and • Outcome-what happens to patients.
Outcome is further categorized by the ECHO model (economic, clinical, and humanistic outcomes). These domains are used in determining what needs to be improved and which measures or sets of measures should be applied.
To execute your quality program, evaluate and consider the three methods frequently used by health care organizations. 7 The lean method, derived from the Toyota Motor Corporation, uses patient outcomes as a goal and then focuses on processes to eliminate waste or any nonvalue-added activities. The optimum sequence for delivery of services to achieve efficiency and quality is developed. Structure and process measurement is used to determine what components of care are critical to producing the desired patient outcome.
Six-sigma is a method focused on reducing variation and defects within processes in order to consistently create a desired outcome. Six-sigma is a statistical term of measurement of the level of defects per million opportunities. Six-sigma represents nearly an error free process.
The steps in the six-sigma process are (1) identify and define what needs to be improved; (2) measure by collecting data; (3) analyze the results; and (4) use creative solutions to improve and then control the process with policies, guidelines, and strategies. Standard order sets are an example of the six-sigma method. (In the hospital setting, the lean and six-sigma methods may be more effective than other means of addressing complex clinical quality and safety issues. 8 )
Perhaps the most widely used method of quality improvement in health care is one based on trial and learning in a rapid cycle of improvement, or the Plan, Do, Study, Act cycle (PDSA cycle). This method utilizes three key questions:
• What are we trying to accomplish?
• What change can we make that will result in improvement?
• How will we know that a change is an improvement?
Questions flow into a cyclic method of steps (plan, do, study, act). In the "planning" stage, aims are established based on what you are trying to accomplish, strategies for change are developed, and measures are chosen that will determine if you achieved your aim. The "do" stage is characterized by implementing the change, which is followed by the "study" phase where the change is tested using the defined measures. In the "act" phase, the results from the study phase are used to re-enter the cycle for further improvement.
A search for better methods continues in response to the slow pace of quality improvement in health care. Kleinman and Dougherty have recently proposed a model for quality improvement that is more patient-and practice-centered. 9 They break down the patient care process domains into actions of quality. The first action is the patient entering the system through awareness by the patient or from a provider. The second action is an assessment that care is needed for the patient. The third action is where a management plan is developed, coordinated, executed, and reassessed. Superimposed on the actions of quality are interpersonal tasks that involve the patient. Quality and patient outcomes are influenced by (1) how well information was obtained from the patient (i.e., the patient as a data repository); (2) how much the patient's beliefs, preferences, culture, etc., were considered (i.e., the patient as an individual); (3) how much the patient participated in decision-making (i.e., the patient as a person); and (4) how well the patient participates in the plan (i.e., the patient as a partner). This method suggests that to improve quality we must measure the quality of each interaction the patient has with a provider and an organization. This interesting approach, which includes the patient's role in attainment of quality, deserves further study.
Applying the principles
Use of well-established quality domains, the identified outcome categories, or the Klleinman-Dougherty 9 quality model to critically look at your particular care delivery system will assist you in identifying areas that need improvement. Which method you ultimately use for implementation of your quality improvement plan will depend in part on the culture and structure of your organization. The lean and six-sigma methods tend to focus on structure and process, and to accomplish the goals may require a larger team and implementation at a higher organizational level. For the ambulatory care practitioner, the PDSA cycle is manageable for a small or solo practice and can be used for an improvement issue in any of the domains of quality, often over a short period of time. The key to a successful quality program is incorporating the chosen quality improvement process into the daily workflow. Consider using technicians and students to support a quick process of data collection for your patient visits. PDSA lends itself to a busy environment and may be the optimal process depending on your organizational goals, environment, and resources available.
Over the past few years there has been an increased focus on outcomes versus other domains of measurement. Many stakeholders are interested in knowing that a positive outcome was consistently achieved rather than knowing exactly how it was achieved. There is much heterogeneity in patient populations and the practice strategies to meet their needs; therefore, it is difficult to make structure and process measurements universal. Focusing purely on structure or process without measuring outcome may yield an inadequate result. Outcome measures are critical and need to be part of any measurement plan. To put it simply, outcome measures are the transparent data regarding your services that must be seen by all-patients, other providers, payers, and others.
Likewise, at the practice or organization level, focusing only on outcomes is not advisable. When focusing only on one domain, the chances of overall improvement are diminished. For example, if reduction in blood pressure is an outcome goal, but you did not pay attention to structure (e.g., training staff to measure blood pressure and reduce excessive patient wait times), you may not achieve optimum outcomes. Certain outcomes are difficult to measure due to rare occurrence, in which case process becomes the optimal measurement. An example is immunizations. It would not be desirable to wait for an outcome that shows decreased rates of chicken pox infection but rather to measure the process of varicella immunization and assume it is preventing chicken pox. A common strategy in the business world is the use of a balanced scorecard where one or two measures are selected in each domain around an improvement focus.
For example, if improvement is focused on medication adherence, at least one measure representing structure, process, outcome, and financial issues are incorporated into the plan.
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Essential characteristics of quality measures. The most influential place for quality to occur and ultimately move the U.S. health system toward improvement is at each patient encounter. This highlights the importance of each practitioner's commitment to quality. Every measure you select must possess three qualities.
First, the measure must be meaningful to you and your patients. Measure an area that is known to need improvement or that is universally recognized as problematic, such as medication adherence or adverse drug events. If you know that a measure is for something that is not a problem in your practice, do not measure it.
Second, the measure must be feasible. Are the data readily available? How disruptive will collecting the data be in the normal process of care? How timely will the analysis be? What resources are needed, and do we have them? The measures that yield positives answers to these questions should rise to the top.
Third, measures should be actionable. You must be able to use the results you get. Make sure the driver of your performance is something that you can change. If you need to go through your organization's hierarchy to make the change, be sure to get leaders' buy-in so that they will allocate the resources you may need to implement changes based on the results of quality measurement.
The entire process of quality measurement requires careful and critical thought at the practice level-from determining improvement goals, choosing measures, and evaluating results.
Avoid using a turnkey approach to measurement that bypasses any critical analysis of your program. For example, as a provider I may lower the average LDL to 90 mg/dL in my population with diabetes through patient education and promoting improved medication adherence. My colleagues providing the same services may lower the LDL to 105 mg/dL in their particular population, also with diabetes. On the surface it might be concluded that that I provide a higher quality service. However, if in my population the LDL level I started with was 105 mg/dL and in my colleagues' population it was 180 mg/dL, who has made the greater quality impact? The greatest improvement in patient morbidity and mortality would probably occur in the population that did not meet the measurement goal but that had the greatest reduction in the quality gap.
Close scrutiny and understanding of what you are measuring and how the result applies to your clinic setting is mandatory. The example presented emphasizes the need for measures to be of high quality and truly measuring outcomes. 11 It highlights the need for further analysis and research in the development and use of measures, especially for many that are currently considered a gold standard. A stronger partnership between academic research, clinical care, and quality measurement needs to be built.
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Barriers to quality improvement. There are likely to be barriers to your quality program, most notably a lack of technology to support efficiency and timeliness of measurement.
Attribution of outcomes specifically to ambulatory care pharmacy services may also be problematic, particularly in interdisciplinary team-based care. This raises the question of whether measurement should reflect the performance of the team versus that of the individual practitioner. Nonetheless, many ambulatory care pharmacists will be asked to demonstrate their specific contribution to quality of care to justify their role. Research and innovative ideas are required to resolve this conundrum. Application of quality improvement principles in health care is a relatively new pursuit, and advancement in this application will depend on the creativity of practitioners and their learning from each other.
Limited progress in health care improvement
To adequately approach improvement, it is important to understand where one is starting from. Unfortunately, for the U.S. health care system, the report card on quality improvement is dismal, especially when considering the amount of resources devoted to health care. The eye opener for the health care industry was the 1999 IOM report To Err Is Human: Building a Safer Health System, which brought to everyone's attention the extent of harm being done to patients. 14 More than 100,000 patient deaths in hospitals were occurring yearly with a major source of error involving medications. Since then, the IOM has published a series of reports focusing on quality and health care, including the 2013 report Closing the Quality Gap: Revisiting the State of the Science. 15 This report describes how quality and optimal patient outcomes remain elusive in the U.S. health care system regardless of the population or type of service evaluated. For every patient that receives optimal care, one does not. 16, 17 In 2012, the Agency for Healthcare Research and Quality (AHRQ) reported that although overall health care quality is improving, it is occurring at a very slow pace. 18 Quality patient care and access remain suboptimal and inconsistent, with worsening access issues and no improvement in health care disparities. In 2000, the United States ranked 38th in health status among industrialized nations, 19 and two reports in 2013 show little improvement in that ranking. 20, 21 Limited progress also has been made in improving medication-related problems. A recent report suggests that nonadherence to medication, suboptimal use of evidence-based drug therapy, antibiotic misuse, medication errors, poor generic utilization, and mismanaged polypharmacy in the elderly is a $200 billion annual problem. 22 In 2003, Gandhi's classic article highlighted the high rate of preventable adverse drug events in the ambulatory care setting. Ten years later, there appears to be little improvement as three recent studies report similar rates of adverse medication events. [23] [24] [25] [26] Although there are pockets of improvement in medication adherence with rates up to 80% or higher, a 2012 report from CVS/Caremark Research Institute suggests that the majority of medication adherence rates remain in the 50% to 60% range. 27 Patients and the public are not blind to quality issues in health care. Adult Americans in a poll conducted several years ago by the Harvard School of Public Health believed the quality of U.S. health care is average at best. 28 Over half the respondents graded quality of care as a C or D, and 1 out of 10 gave a failing grade. The poll also suggests that patients are beginning to consider quality of care in choosing providers.
There are no clear answers and many theories as to why our health care system is struggling to improve. One theory is that we rarely ask patients what their preferences are for services, and unless we address what is important to them, we will not advance quality metrics. 12, 29 For example, there are many iterations of a medication list but few reports 30, 31 on what patients want in such a tool. Patient engagement and patient wishes are expected to become more important in quality measurement.
Another theory is that the application of rigorous science in evaluating quality improvement processes is being trumped by pressure to implement new but untested methods and ideas. Improvement of clinical systems is not a research priority for many academic institutions. 12 Concern exists by others that there is too great a reliance on surrogate markers and not enough on the drivers of change. 11 For example, how can we truly achieve quality care for the diabetic population by focusing only on vigilant therapeutics and patient monitoring and not on issues related to transportation, food advertising, workplace design, or other underlying societal causes of the epidemic? An additional opinion is that the health care quality industry has not identified the highest priorities for measurement, such as patient safety, or has not concentrated on using measures that are of highest value. 9 As one IOM report states, if banking were like health care the automated teller transaction would take days or longer due to unavailable or misplaced records; if home building were like health care, carpenters, electricians, and plumbers each would work off different blueprints with very little coordination. 32 As health care providers, we can articulate the problems; the difficulty is improving at an acceptable pace.
Ongoing efforts to improve
Many organizations are working on improving the quality of the nation's health system. Collectively, they are developing measures or measurement concepts, using sets of measures for payment or accreditation, and recommending optimal measures for the various segments of health care. These groups include many of the professional organizations such as ASHP and the following bodies, listed here by their initials: NQF, NCQA, TJC, PQA, PCPI, CMS, PQRS, AHRQ, HEDIS, CPPA, URAC, PCPCC, and IHI. Thus far, there has been a lack of coordination among the groups, which has led to a plethora of measures and multiple entities holding organizations and providers accountable for a variety of quality measures. The National Quality Strategy, mandated by the Affordable Care Act, has set priorities for quality improvement in health care and has developed a plan for achieving these priorities (ahrq.gov/workingforquality/about.htm). Although a relatively young science, quality improvement is causing measurement weariness, cost concerns, and questions about the value that various initiatives are actually having on quality. Several groups have recognized this concern and are working toward alignment, prioritization, and grouping of measures to ease this burden.
Overview of national quality organizations in health care
Government-related organizations. The federal government and government-supported organizations are extremely influential in dictating the direction of the quality movement. Many resources from the federal government are readily available on the Web. Governmental efforts start with the Triple Aim, which sets the agenda and approach to improving quality through three tenets:
• Better care for individuals,
• Better health for populations, and • Reducing per-capita costs.
Better care for individuals is driven by the six dimensions of health care performance from the IOM report Crossing the Quality Chasm and the six priorities of the National Quality Strategy, which are listed in Table 1 directly affects a number of these measures (see Table 2 on the next page). These measures are doubly important because they may be tied to future pay-for-performance initiatives.
Additionally, AHRQ has developed a collection of 100 evidence reports over the past nine years titled Closing the Quality Gap Series. 34 Many of the reports relate to ambulatory care, including chronic conditions such as diabetes and osteoporosis and medication adherence and medication management. The reports do not define quality measures but can be used to guide your practice around best evidence. The National Quality Measures Clearinghouse (NQMC) is a public resource for evidence-based quality measures housed by AHRQ. 36 More than 8000 measures currently reside in the database. Despite this large number, the value of this site is that the measures are categorized, providing information to evaluate measures for validity, importance, scientific soundness, and feasibility. The search functions are user friendly, provide a variety of options, and can drill down to specific results. In your practice, once you have identified areas of interest to measure, the ability to search this site for tested measures in those areas makes the NQMC an extremely valuable resource.
Institute of Medicine (IOM).
A number of organizations, although independent, have strong affiliation with the federal government and origins that stem from laws or other government initiatives. In 1970, the IOM, an independent nonprofit organization, was established under the National Academy of Sciences. The IOM's role is to work outside government to provide unbiased and authoritative advice to decision makers and the public.
Much of its work is commissioned by the government. The IOM has nearly 200 reports on health care quality and patient safety, including reports discussed above. Its most recent report,
Core Measurement Needs for Better Care, Better Health, and Lower Cost: Counting What
Counts, addresses the lack of alignment and prioritization of measures and proposes a set of core measures around the Triple Aim. 37 The report provides an excellent framework for organizations or practices to build a core measure set that aligns with the Triple Aim and the National Strategy for Quality. Practitioners new to quality measurement can build their measurement process around this framework, and those who are experienced with quality measurement may want to organize their program in this framework to ensure better comparison with the performance of others. Table 3 
Pharmacy Quality Alliance (PQA

Quality Improvement Organizations (QIOs). QIOs are independent organizations
contracted with CMS to improve the effectiveness, efficiency, economy, and quality services 
Patient Safety and Clinical Pharmacy Services Collaborative (PSPC).
With the current initiative to reduce adverse drug events, the QIOs have partnered with pharmacy through the PSPC. 38 The PSPC was initiated by the Health Resources and Services Administration (part of HHS) six years ago to address adverse medication events for uninsured, isolated, or medically vulnerable patients served by "safety-net" providers such as federally qualified health centers (FQHCs). The teams use the PDSA process to achieve the PSPC goal of integrating clinical pharmacy services in the safety-net setting and improve patient safety and health outcomes.
Results from the over 250 participating teams on quality outcomes to date are impressive. 39, 40 Membership has expanded beyond safety-net providers to include any multidisciplinary, community-based group with high-risk patients, who either have integrated or are able to integrate clinical pharmacist services and are willing to work on the "change package" of the affected by payers using these measures, it is important for ambulatory care pharmacists to review and consider these measures in their work.
NCQA also provides accreditation, certification, and recognitions programs, including accountable care organization accreditation, patient-centered medical home (PCMH) recognition, and a diabetes-management recognition program. The PCMH recognition program has generated high interest because a number of payers provide payment incentives to ambulatory care organizations that achieve recognition. NCQA is currently working to synchronize the PCMH standards with "meaningful use" (see below) measures from CMS. Within PCMH standards, measures for coordination of care, medication management, population health, and care planning are relevant to ambulatory care pharmacists. Comprehensive accreditation of ambulatory care pharmacy services is just beginning to evolve. How accreditation will affect this field is yet to be determined. Surprisingly, research studying the effect of health care organization accreditation on health care quality and patient outcomes is relatively scant with mixed results at best. 42, 43 Nonetheless, accreditation is firmly established in the health care industry and is yet another area that ambulatory care pharmacists must stay informed about.
Center for Pharmacy Practice Accreditation (CPPA)
.
Payers.
Payers have an obligation to their enrollees to assure they are paying a fair price for quality services; thus they have a vested interest in developing quality-related incentives.
Both private payers and the government have adopted pay-for-performance (P4P) and valuebased purchasing initiatives. P4P is a program that provides (1) bonus payment to providers if they meet or exceed quality or performance measures or (2) financial penalties to those who do not achieve certain goals or cost savings or (3) both. 44 Value-based purchasing plans are health insurance designs that encourage, through payment incentives, use of evidence-based, high-value services that produce desired outcomes and discourage use of services that are considered low value or without evidence; the plans may also incentivize enrollees to adopt healthy lifestyles and select high-performing providers. 45, 46 Medicare. There national priorities, include morbidity and mortality of beneficiaries, conditions of disproportionate cost, and those that would enable CMS to make comparisons across the provider community. 48 Starting in January 2014, Medicare Part B eligible providers must report at least three months of data on nine of the 64 approved measures that cover at least three of the national priority domains. This presents another opportunity for ambulatory care pharmacists to assist their organizations in meeting these requirements.
Also relevant to ambulatory care pharmacists is the CMS hospital readmissions reduction program, which reduces payments to hospitals with excess readmissions. 49 Ambulatory care pharmacists who have a relationship with a hospital will have many opportunities to help the institution ensure that discharged patients experience good outcomes and do not trigger payment reductions. 
Contributions of the ambulatory care pharmacist
With any big problem come big opportunities, and the opportunities are tremendous for ambulatory care pharmacists to improve the safety and quality of medication use and the outcomes of patients. As previously stated, gaps in quality are occurring daily in our practices, and patients are experiencing unacceptable medication-related problems. Pressures are increasing on health systems, hospitals, physician groups, payers, and pharmacists to improve the quality of care. Payment changes and financial incentives are stimulating quality improvement in all health care organizations. It is vital for ambulatory care pharmacists to understand this environment because many measures of health care quality are related to their work (see Table 4 below).
Continuing to carve out an essential role in improving the quality of medication use is imperative for gaining payment for ambulatory care pharmacist services. As pharmacists integrate into the new models of ambulatory care, they must be well informed about current and emerging performance measures required for payment, accreditation, or certification.
Understanding the focus and role of the specific quality improvement groups affecting your organization will help you demonstrate the value of ambulatory care pharmacist services to patients, the parent or collaborating organization, and the overall health care enterprise.
Conclusion
In preparing this paper, the fact that the United States has made minimal progress in improving the quality of health care has weighed heavily on my mind. Although uncoordinated, significant resources have been devoted toward quality improvement, mostly at a high conceptual level. In practice, most clinicians are trying to provide the best services they can to their patients. Yet rarely are individual practitioners overtly addressing quality improvement in This situation reminds me of medical error. The problem must be fixed from the bottom up, not the top down. Just like error, quality occurs primarily at the patient-provider interface.
As with patient safety, systems need to place practitioners in environments where it is hard not to provide quality services and where they are empowered to fix lapses in quality. For that reason, implementing the PDSA cycle as a method of quality improvement makes sense, because it allows for quick, albeit small, practice changes where individual practitioners fix any quality gap they encounter. The role of managers and organizational leaders in this scenario is to coordinate and consolidate many small practitioner-initiated changes into measurable quality improvement for the organization as a whole.
As pharmacists pursue a better practice model in ambulatory care, it is the perfect time to find ways to incorporate quality improvement into everyday practice. Imagine the progress that could be made if every ambulatory care pharmacist focused on quality improvement for one hour a day or one afternoon a week. With payment incentives now aligned with quality, there is a business case for this element of a pharmacy practice model, which has immense potential for improving the overall quality of patient care.
